![Catherine Isted](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Catherine Isted
Direttore Finanziario/CFO presso
SANTHERA PHARMACEUTICALS HOLDING AG
Profilo
Catherine Isted currently works at Santhera Pharmaceuticals Holding AG, as Chief Financial Officer from 2025.
Ms. Isted also formerly worked at ReNeuron Group Plc, as Chief Executive Officer & Executive Director from 2022 to 2023, Oxford Biomedica Plc, as Head-Corporate Development & Investor Relations from 2019 to 2021, Nomura Code Securities Ltd., as Sales Associate from 2009 to 2013, Peel Hunt LLP, as Sales Associate from 2015 to 2019, and BenevolentAI SA, as Chief Financial Officer from 2023 to 2024.
Posizioni attive di Catherine Isted
| Società | Posizione | Inizio |
|---|---|---|
| SANTHERA PHARMACEUTICALS HOLDING AG | Direttore Finanziario/CFO | 24/02/2025 |
Precedenti posizioni note di Catherine Isted
| Società | Posizione | Fine |
|---|---|---|
| BENEVOLENTAI S.A. | Direttore Finanziario/CFO | 03/07/2024 |
| RENEURON GROUP PLC | Amministratore Delegato | 03/01/2023 |
| OXFORD BIOMEDICA PLC | Public Communications Contact | 01/10/2021 |
Peel Hunt LLP
 Peel Hunt LLP Investment Banks/BrokersFinance Provides brokerage services | Vendite & Marketing | 01/01/2019 |
Nomura Code Securities Ltd.
 Nomura Code Securities Ltd. Investment ManagersFinance Provides advisory, fundraising, and broking services | Analyst-Equity | 17/07/2009 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
70
Relazioni di 1° grado
6
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 6 |
|---|---|
ReNeuron Group Plc
 ReNeuron Group Plc Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops and manufactures cell-based therapy products | Health Technology |
Oxford Biomedica Plc
 Oxford Biomedica Plc BiotechnologyHealth Technology Operates as a contract development and manufacturing organization which provides viral vectors to pharmaceutical and biotechnology clients in cell and gene therapy fields | Health Technology |
Santhera Pharmaceuticals Holding AG
 Santhera Pharmaceuticals Holding AG Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for the treatment of neuromuscular diseases | Health Technology |
Nomura Code Securities Ltd.
Nomura Code Securities Ltd. Investment ManagersFinance Provides advisory, fundraising, and broking services | Finance |
Peel Hunt LLP
Peel Hunt LLP Investment Banks/BrokersFinance Provides brokerage services | Finance |
BenevolentAI SA
 BenevolentAI SA Packaged SoftwareTechnology Services Develops AI drug discovery platform to accelerate biopharma drug discovery | Technology Services |
